<DOC>
	<DOCNO>NCT00302133</DOCNO>
	<brief_summary>The purpose study test efficacy naltrexone valproate treatment comorbid bipolar disorder alcohol dependence .</brief_summary>
	<brief_title>Optimizing Pharmacotherapy Bipolar Alcoholics</brief_title>
	<detailed_description>Bipolar disorder high rate association alcohol substance use disorder . This complex clinical presentation asociated severe disability , morbidity heighten risk suicide . There significant gap knowledge regard effective treatment intervention high risk clinical population . This proposal test efficacy promise pharmacological approach treatment comorbid alcohol dependence bipolar disorder . We propose randomize , double blind , placebo control 12-week trial test efficacy valproate plus naltrexone vs. valproate alone decrease alcohol use stabilize mood symptom among patient comorbid alcohol dependence bipolar disorder . All participant receive supportive psychosocial treatment .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Subjects meet Diagnostic Statistical ManualIV ( DSMIV ) criteria current alcohol dependence concurrent bipolar disorder 1 ) Schizophrenia , schizoaffective nonbipolar psychotic disorder , unipolar major depression , primary anxiety disorder , mental retardation sign impair cognitive functioning . 2 ) Opiate dependence , abuse , opioid maintenance treatment reason positive urine screen opiate . 3 ) Current DSMIV criterion dependence substance alcohol , cannabis , nicotine caffeine . 4 ) Neurological condition include epilepsy , history brain injury , encephalitis organic brain syndrome document focally abnormal EEG . 5 ) Medical condition include severe cardiac , liver , kidney , endocrine , hematologic , impair medical condition , impend surgery 6 ) Pregnancy 7 ) Inability unwillingness use contraceptive method 8 ) Any medical condition reason opinion investigator would prevent subject complete protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Alcoholism Bipolar Disorder Pharmacotherapy Naltrexone</keyword>
</DOC>